Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 15,000 shares at $15.00 ($225K) on 2015-08-04, disclosed to the SEC on 2015-08-05.
Open-market purchase of $225k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |